Carlos Thiene Pachón

Cardiologist | Cardioneuroablation developer (CNA) | AI builder

[Carlos Thiene Pachón @thienepachon]

Why would evolution create a nerve that stops the heart? 🤔

700 million years of answers, now in one book.
📚 "Cardioneuroablation A Comprehensive Guide From the Creators"

The first complete guide by Pachon, Pachon & Pachon.
🧠 AF-Nest & spectral analysis
⚡ Vagal denervation step-by-step
🫀 Pacemaker-free solutions
Foreword: Prof. Josep Brugada

👉 https://t.co/dHkdVC97Ec

#EPeeps #CardioTwitter #Cardioneuroablation #AFib #HeartRhythm

[Carlos Thiene Pachón @thienepachon]

Our patent has been granted in the United States! Extracardiac Autonomic Nerve Stimulation, issued on August 18, 2026.

Although the grant was only completed now, this device and this technique have already been helping thousands of patients around the world for many years. That is what makes us happiest: being able to help people who suffer from syncope and arrhythmias.

This is, without a doubt, the biggest win of my life so far.

Not because of the patent itself, but because of the road to it. It took years of study and dedication in very different fields, well beyond medicine. We had to step into territory that was not our own, learn from zero more than once, and sustain the project inside another country's system, with its own rules and demands.

It was the greatest challenge I have ever faced. Sharing it with so many of you who followed it closely is part of what makes this achievement real.

Alongside my father, José Carlos Pachón, and my uncle, Enrique Pachón, co-inventors of this patent, I feel truly fulfilled. And I now understand, in full, the lesson that Prof. Zerbini and Prof. Adib Jatene, two giants of Brazilian cardiac surgery, taught us: "Nothing, absolutely nothing withstands work."
#cardioneuroablation #USPTO

[Carlos Thiene Pachón @thienepachon]

@rom1trs OS pls! Tnks

[HeartRhythm @hrs_journal]

Catheter ablation vs antiarrhythmic drug therapy for first-line treatment of atrial fibrillation in United States clinical practice

https://t.co/9yQLIWUMXx

[Carlos Thiene Pachón @thienepachon]

Something weird is happening with AI usage limits.

Both my OpenAI and Anthropic usage meters returned to 100%, and about R$1,000 in credits appeared on my Anthropic account.

Here’s what I observed and what’s public. 🧵
@lucas_montano

[Carlos Thiene Pachón @thienepachon]

@rom1trs VOX

[Carlos Thiene Pachón @thienepachon]

@aakashgupta @zesaid

[Carlos Thiene Pachón @thienepachon]

Clinicians using Claude for research: heads up.

Opus 4.7 has a dangerous pattern. It tells you it analyzed your paper, but often substitutes training knowledge for actual data extraction. The report looks great. The fidelity to your source? Not guaranteed.

Opus 4.6 read what you gave it. 4.7 sometimes pretends to.

For medical data analysis, this is a dealbreaker. A confident wrong summary of a clinical trial is worse than no summary at all.

Verify everything. @AnthropicAI, please fix this. The platform is too good to lose trust over silent shortcuts.
@lucas_montano

[Carlos Thiene Pachón @thienepachon]

Our paper on long-term outcomes of cardioneuroablation with and without extracardiac vagal stimulation (ECVS) confirmation was recognized as a Top Cited Article 2025 by @WileyHealth in the Journal of Cardiovascular Electrophysiology.
ECVS, developed by our group over 10 years ago, as a procedural endpoint makes a measurable difference in outcomes.
Grateful to our coauthors and the SEMAP/hcor team.
@JCardioEP #cardioneuroablation #Syncope #NeurocardiogenicSyncope @WileyGlobal #EPeeps #CardioTwitter #Electrophysiology #Cardiology
https://t.co/aXQpy6EHoJ #TopCitedArticle @wileyinresearch @PachonMateos @Pachon_CNA